Identification and management of alcohol withdrawal syndrome

A Mirijello, C D'Angelo, A Ferrulli, G Vassallo… - Drugs, 2015 - Springer
Symptoms of alcohol withdrawal syndrome (AWS) may develop within 6–24 h after the
abrupt discontinuation or decrease of alcohol consumption. Symptoms can vary from …

Progress on transition metal catalyzed asymmetric hydroesterification, hydrocarboxylation, and hydroamidation reactions of olefins

J Li, Y Shi - Chemical Society Reviews, 2022 - pubs.rsc.org
Hydrocarboxylation, hydroesterification, and hydroamidation of olefins are fundamental
transformations in organic synthesis. Asymmetric processes for these transformations …

Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled …

G Addolorato, L Leggio, A Ferrulli, S Cardone… - The Lancet, 2007 - thelancet.com
Background Intervention to achieve alcohol abstinence represents the most effective
treatment for alcohol-dependent patients with liver cirrhosis; however, anticraving drugs …

[PDF][PDF] Concepts of chemical dependency

HE Doweiko - Psychiatry, 1999 - wpunj.edu
Bowen, S., Witkiewitz, K., Clifasefi, SL, Grow, J., Chawla, N., Hsu, SH, Carroll, HA, Harrop, E.,
Collins, SE, Lustyk, MK, & Larimer, ME (2014). Relative efficacy of mindfulness-based …

Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint?

J Frascella, MN Potenza, LL Brown… - Annals of the New …, 2010 - Wiley Online Library
For more than half a century, since the beginning of formal diagnostics, our psychiatric
nosology has compartmentalized the compulsive pursuit of substance (eg, alcohol, cocaine …

Chemistry and pharmacology of GABAB receptor ligands

W Froestl - Advances in pharmacology, 2010 - Elsevier
This chapter presents new clinical applications of the prototypic GABA B receptor agonist
baclofen for the treatment of addiction by drugs of abuse, such as alcohol, cocaine, nicotine …

Management of alcohol dependence in patients with liver disease

G Addolorato, A Mirijello, L Leggio, A Ferrulli… - CNS drugs, 2013 - Springer
Alcohol dependence represents a chronic and relapsing disease affecting nearly 10% of the
general population both in the USA and in Europe, with a widespread burden of morbidity …

New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications

L Leggio, GA Kenna, RM Swift - Progress in Neuro-Psychopharmacology …, 2008 - Elsevier
Alcohol withdrawal syndrome (AWS) can be a life-threatening condition affecting some
alcohol-dependent patients who abruptly discontinue or decrease their alcohol …

Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up

AM Ponizovsky, P Rosca, E Aronovich… - Journal of Substance …, 2015 - Elsevier
Background Limited clinical trials and case-reports yielded conflicting results regarding the
efficacy of baclofen (a GABAB agonist) in the treatment of alcohol dependence. The aim of …

GABAB receptors in reward processes

S Vlachou, A Markou - Advances in pharmacology, 2010 - Elsevier
Abstract γ-aminobutyric acid (GABA) is the predominant inhibitory neurotransmitter in the
brain which acts through different receptor subtypes. Metabotropic GABA B receptors are …